Literature DB >> 17005639

Rotavirus infection enhances lipopolysaccharide-induced intussusception in a mouse model.

Kelly L Warfield1, Sarah E Blutt, Sue E Crawford, Gagandeep Kang, Margaret E Conner.   

Abstract

Unexpected reports of intussusception after vaccination with the live tetravalent rotavirus vaccine RotaShield resulted in voluntary withdrawal of the vaccine. Intussusception, a condition in which the intestine acutely invaginates upon itself, is the most common cause of intestinal obstruction in children. We report here the development of a mouse model to study rotavirus-induced intussusception. In this model, both homologous murine and heterologous simian rotavirus strains significantly enhanced the rate of lipopolysaccharide (LPS)-induced intussusception, and this enhancement was replication dependent, requiring rotavirus doses of greater than one 50% infectious dose. Rotavirus-induced intussusceptions did not have observable lymphoid lead points, despite the induction of intestinal lymphoid hyperplasia after rotavirus infection. Intussusceptions are also postulated to result from altered intestinal motility, but rotavirus infection had no effect on gastrointestinal transit. LPS-induced intussusception is associated with the induction of inflammatory mediators, and intussusception rates can be modified by inflammatory antagonists. We show that rotavirus infection significantly enhanced serum tumor necrosis factor alpha and gamma interferon cytokine levels after LPS treatment compared to uninfected mice. Together, these data suggest that rotavirus infection sensitized mice to the inflammatory effects of subsequent LPS treatment to enhance intussusception rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005639      PMCID: PMC1676276          DOI: 10.1128/JVI.01185-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

Review 1.  Intussusception among young children in Europe.

Authors:  Hans-Iko Huppertz; Montse Soriano-Gabarró; Emmanuel Grimprel; Elisabetta Franco; Zsofia Mezner; Ulrich Desselberger; Yolba Smit; Judith Wolleswinkel-van den Bosch; Beatrice De Vos; Carlo Giaquinto
Journal:  Pediatr Infect Dis J       Date:  2006-01       Impact factor: 2.129

2.  Intussusception and rotavirus associated hospitalisation in New Zealand.

Authors:  Y E Chen; S Beasley; K Grimwood
Journal:  Arch Dis Child       Date:  2005-06-17       Impact factor: 3.791

3.  Intussusception, rotavirus diarrhea, and rotavirus vaccine use among children in New York state.

Authors:  H G Chang; P F Smith; J Ackelsberg; D L Morse; R I Glass
Journal:  Pediatrics       Date:  2001-07       Impact factor: 7.124

4.  Intussusception among infants given an oral rotavirus vaccine.

Authors:  T V Murphy; P M Gargiullo; M S Massoudi; D B Nelson; A O Jumaan; C A Okoro; L R Zanardi; S Setia; E Fair; C W LeBaron; M Wharton; J R Livengood; J R Livingood
Journal:  N Engl J Med       Date:  2001-02-22       Impact factor: 91.245

5.  Nitric oxide synthase/nitric oxide pathway mediates intussusception pathogenesis in rats.

Authors:  P Wang; B Liu; H Ou; L Tong; J Yang; C Tang
Journal:  Chin Med J (Engl)       Date:  1999-11       Impact factor: 2.628

6.  [Purpura with intestinal invagination and infection due to Malassez-Vignal bacillus].

Authors:  R Mallet; H H Mollaret; M Ribierre; L Reyrole; B Labrune; J F Feron
Journal:  Bull Mem Soc Med Hop Paris       Date:  1966-05-27

7.  Interferon-alpha in viral and bacterial gastroenteritis: a comparison with C-reactive protein and interleukin-6.

Authors:  P Mangiarotti; F Moulin; P Palmer; S Ravilly; J Raymond; D Gendrel
Journal:  Acta Paediatr       Date:  1999-06       Impact factor: 2.299

8.  Effect of rotavirus vaccination programme on trends in admission of infants to hospital for intussusception.

Authors:  L Simonsen; D Morens; A Elixhauser; M Gerber; M Van Raden; W Blackwelder
Journal:  Lancet       Date:  2001-10-13       Impact factor: 79.321

9.  Cytokines as mediators for or effectors against rotavirus disease in children.

Authors:  B Jiang; L Snipes-Magaldi; P Dennehy; H Keyserling; R C Holman; J Bresee; J Gentsch; R I Glass
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

10.  Intussusception, adenovirus, and children: a brief reaffirmation.

Authors:  E A Montgomery; E J Popek
Journal:  Hum Pathol       Date:  1994-02       Impact factor: 3.466

View more
  7 in total

1.  Role of innate immunity and altered intestinal motility in LPS- and MnCl2-induced intestinal intussusception in mice.

Authors:  Kristin E Killoran; Amber D Miller; Karen S Uray; Norman W Weisbrodt; Robia G Pautler; Sanna M Goyert; Nico van Rooijen; Margaret E Conner
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-09       Impact factor: 4.052

2.  Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

Authors:  Stefan Schild; Eric J Nelson; Andrew Camilli
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

3.  Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice.

Authors:  N Feng; B Kim; M Fenaux; H Nguyen; P Vo; M B Omary; H B Greenberg
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

4.  Contaminated Shipping Materials Identified as the Source of Rotaviral Infection of Exported Mice.

Authors:  Krista E Lindstrom; Kenneth S Henderson; Melinda S Mayorga; Veronica A Kuiper; James D Wilkerson
Journal:  J Am Assoc Lab Anim Sci       Date:  2018-08-14       Impact factor: 1.232

Review 5.  Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.

Authors:  Catherine Yen; Kelly Healy; Jacqueline E Tate; Umesh D Parashar; Julie Bines; Kathleen Neuzil; Mathuram Santosham; A Duncan Steele
Journal:  Hum Vaccin Immunother       Date:  2016-06-20       Impact factor: 3.452

6.  Abnormal Blood Bacteriome, Gut Dysbiosis, and Progression to Severe Dengue Disease.

Authors:  Wiwat Chancharoenthana; Supitcha Kamolratanakul; Wassawon Ariyanon; Vipa Thanachartwet; Weerapong Phumratanaprapin; Polrat Wilairatana; Asada Leelahavanichkul
Journal:  Front Cell Infect Microbiol       Date:  2022-06-17       Impact factor: 6.073

7.  Lactobacillus delbrueckii CRL 581 Differentially Modulates TLR3-Triggered Antiviral Innate Immune Response in Intestinal Epithelial Cells and Macrophages.

Authors:  Mariano Elean; Leonardo Albarracin; Kohtaro Fukuyama; Binghui Zhou; Mikado Tomokiyo; Shugo Kitahara; Shota Araki; Yoshihito Suda; Lucila Saavedra; Julio Villena; Elvira M Hebert; Haruki Kitazawa
Journal:  Microorganisms       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.